Artemis Policy Group LLC
Artemis Policy Group LLC filed a Q2 report for Susan G. Komen on July 20, 2026, reporting $40,000 in lobbying income.
Lobbying for Susan G. Komen · organization addressing breast cancer through research, community health, public policy
-
JOHANNA GRAYPreviously held: Intern, Senator Barack Obama
-
LESLIE BRADYPreviously held: Health Policy Advisor/Legislative Assistant, Rep. Brian Higgins
FY27 appropriations for the National Breast and Cervical Cancer Early Detection Program FY27 appropriations for breast cancer research FY27 appropriations for cancer prevention and control
Access to Breast Cancer Diagnosis (ABCD) Act (H.R.3037/S.1500); a bill prohibiting group health plans and health insurance issuers offering group or individual health insurance coverage from imposing cost-sharing requirements with respect to diagnostic and supplemental breast examinations Implementation of the Affordable Care Act Administrative actions necessary to reduce out-of-pocket costs for medical-necessary diagnostic breast imaging Policies related to coverage of preventive services with no cost-sharing Protect patients from substandard and junk insurance products Implementation of One Big Beautiful Bill Act (H.R.1) Policies related to coverage for breast cancer treatments, including breast or chest wall surgical reconstructions
Medicare coverage policy for breast cancer treatments and services Issues related to 1115 and 1332 of the Social Security Act; policies related to work requirements, reinsurance and block grants in Medicaid Medicare coverage policy for drugs and drug pricing Medicare Drug Pricing Negotiation implementation Preserving and expanding access to Medicaid Implementation of H.R. 1, One Big Beautiful Bill Act H.R. 2048, Metastatic Breast Cancer Access to Care Act H.R.8839 - Lainie Jones Comprehensive Cancer Survivorship Act of 2026 Policies related to the operations of pharmacy benefits managers: comments on proposed rules re PBM transparency (EBSA-2026-0001) and prior authorization for prescription drugs (CMS-0062-P) Implementation of Medicaid Community Engagement requirements
Policies related to PBM and drug cost transparency Screening for Communities to Receive Early and Equitable Needed Services for Cancer Act; a bill to amend the Public Health Service Act to reauthorize and improve the National Breast and Cervical Cancer Early Detection Program for fiscal years 2024 through 2028 (H.R.2381/S. 1866) Policies related to the availability and patient awareness of breast cancer risk assessments H.R. 4541, the EARLY Act Reauthorization of 2025 Issues related to the US Preventive Services Task Force